$CTSO Cytosorbents Corp Insider Trading
Get free email notifications about insider trading in Cytosorbents Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cytosorbents Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in Cytosorbents Corp for free.
IRS Number: 980373793
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: CTSO
Company Address: 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION 08852
Phone number: 973-329-8885
Former name: GILDER ENTERPRISES INC, date of change: 2002-06-11
Former name: MedaSorb Technologies CORP, date of change: 2006-08-07
Former name: MedaSorb Technologies Corporation
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Princeton, NJ.
Market Capitalization: $142.62M
Prev close: $5.65
Average Daily Volume: 62,439
Days Low: $5.60
Year Low: $3.11
Year High: $6.90
Cytosorbents Corp Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2021 | CTSO | Cytosorbents Corp | Sobel Alan D. | Director | Option Exercise | A | 8.99 | 17,250 | 155,078 | 17,250 | |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Kraus Al | Director | Option Exercise | A | 8.99 | 34,500 | 310,155 | 34,500 | |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Jones Edward Raymond | Director | Option Exercise | A | 8.99 | 17,250 | 155,078 | 17,250 | |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Offic ... | Option Exercise | A | 8.99 | 63,250 | 568,618 | 63,250 | |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Deliargyris Efthymios | Chief Medical Offic ... | Grant | A | 8.99 | 40,000 | 359,600 | 183,000 | 143 K to 183 K (+27.97 %) |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Chan Phillip P. | Chief Executive Off ... | Option Exercise | A | 8.99 | 96,000 | 863,040 | 96,000 | |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Chan Phillip P. | Chief Executive Off ... | Grant | A | 8.99 | 72,000 | 647,280 | 769,339 | 697.3 K to 769.3 K (+10.32 %) |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Capponi Vincent | President | Option Exercise | A | 8.99 | 78,200 | 703,018 | 78,200 | |
| Apr 14 2021 | CTSO | Cytosorbents Corp | Capponi Vincent | President | Grant | A | 8.99 | 62,215 | 559,313 | 467,756 | 405.5 K to 467.8 K (+15.34 %) |
| Apr 14 2021 | CTSO | Cytosorbents Corp | BLOCH KATHLEEN P. | Chief Financial Off ... | Option Exercise | A | 8.99 | 69,000 | 620,310 | 69,000 | |
| Apr 14 2021 | CTSO | Cytosorbents Corp | BLOCH KATHLEEN P. | Chief Financial Off ... | Grant | A | 8.99 | 49,450 | 444,556 | 375,372 | 325.9 K to 375.4 K (+15.17 %) |
| Apr 14 2021 | CTSO | Cytosorbents Corp | BATOR MICHAEL G. | Director | Option Exercise | A | 8.99 | 17,250 | 155,078 | 17,250 | |
| Jan 04 2021 | CTSO | Cytosorbents Corp | BLOCH KATHLEEN P. | Chief Financial Off ... | Option Exercise | M | 5.60 | 7,857 | 43,999 | 47,793 | |
| Jan 04 2021 | CTSO | Cytosorbents Corp | BLOCH KATHLEEN P. | Chief Financial Off ... | Buy | M | 5.60 | 7,857 | 43,999 | 333,013 | 325.2 K to 333 K (+2.42 %) |
| Nov 12 2020 | CTSO | Cytosorbents Corp | Kraus Al | Director | Option Exercise | M | 3.45 | 8,000 | 27,600 | 0 |